Inspire Medical Systems, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Inspire Medical Systems, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $84.00K, a 15.07% increase year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $83.00K, a 20.29% increase year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $84.00K, a 29.23% increase year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $73.00K, a 14.12% decline year-over-year.
- Inspire Medical Systems, Inc. stock issued during period, value, new issues for fiscal 2025 was $307.00K, a 4.66% decline from fiscal 2024.
- Inspire Medical Systems, Inc. stock issued during period, value, new issues for fiscal 2024 was $322.00K, a 8.78% decline from fiscal 2023.
- Inspire Medical Systems, Inc. stock issued during period, value, new issues for fiscal 2023 was $353.00K, a 8.62% increase from fiscal 2022.
- Inspire Medical Systems, Inc. stock issued during period, value, new issues for fiscal 2022 was $325.00K, a 7.97% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $84.00K 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $83.00K 10-Q · filed 2026-08-03 | |
| 2025-12-31 | $307.00K 10-K · filed 2026-02-13 | |
| 2025-09-30 | $84.00K 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $73.00K 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $69.00K 10-Q · filed 2026-08-03 | |
| 2024-12-31 | $322.00K 10-K · filed 2026-02-13 | |
| 2024-09-30 | $65.00K 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $85.00K 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $101.00K 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $353.00K 10-K · filed 2026-02-13 | |
| 2023-09-30 | $91.00K 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $91.00K 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $90.00K 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $325.00K 10-K · filed 2025-02-10 | |
| 2022-09-30 | $79.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $80.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $79.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $301.00K 10-K · filed 2024-02-09 | |
| 2021-09-30 | $77.00K 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $72.00K 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $73.00K 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $294.00K 10-K · filed 2023-02-10 | |
| 2020-09-30 | $72.00K 10-Q · filed 2021-11-02 | $276.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $73.00K 10-Q · filed 2021-11-02 | $262.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $72.00K 10-Q · filed 2021-11-02 | $247.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $233.00K 10-K · filed 2022-02-15 |
| 2019-09-30 | $58.00K 10-Q · filed 2020-11-02 | $232.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $58.00K 10-Q · filed 2020-11-02 | $211.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $58.00K 10-Q · filed 2020-11-02 | $112.19M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $95.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $37.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $112.04M 10-Q · filed 2019-08-06 | |
| 2017-12-31 | $24.97M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $12.35M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |